02563 BIOSTAR PHARM-B
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 8.83X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | N/A |
| Total Debt/Equity | 0.2% | Return on Equity | N/A |
| Price/Book | 3.88X | Return on Assets | N/A |
| (HKD 8.960) | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | -152.91 | -209.03 | -179.96 |
|---|---|---|---|
| Net Profit Growth (%) | +26.9 | -16.2 | N/A |
| Earnings Per Share (HKD) | -0.434 | -0.597 | -0.514 |
| Earnings Per Share Growth (%) | +27.4 | -16.1 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | 2.307 | N/A | N/A |
| Auditors' Opinion | Qualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-07 21:40:22
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | |
| Cover Period (mths) | 6 | 6 | NA | |
|---|---|---|---|---|
| Turnover | 14.787 | 33.123 | -55.4 | |
| Operating Result | -55.733 | -70.557 | -21.0 | |
| Profit Before Taxation | -54.041 | -70.56 | -23.4 | |
| Profit /( Loss) After Taxation | -54.041 | -70.56 | -23.4 | |
| Net Profit | -54.041 | -70.56 | -23.4 | |
| Earnings Per Share () | -0.1624 | -0.2167 | -25.1 | |
| Announcement Date | 2025-08-28 | 2025-08-28 | NA |
* Annualised
Last Update Time: 2025-09-07 21:40:27
